Resistin in mid-trimester amniotic fluid in trisomy 21

References

• Frid C, Drott P, Lundell B, et al. Mortality in Down’s syndrome in relation to congenital malformations. J Intell Disabil Res 1999;43:234–41
   PubMed Web of Science ®Google Scholar
• Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988;81:102–10
   PubMed Web of Science ®Google Scholar
• Angelopoulou N, Souftas V, Sakadamis A, Mandroukas K. Bone mineral density in adults with Down’s syndrome. Euro Radiol 1999;9:648–5
   PubMedGoogle Scholar
• Iliodromiti S, Vrachnis N, Samoli E, et al. Fetuin a concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerations. Mediators Inflam 2012;2:138971
   Google Scholar
• Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004;255:439–47
   PubMed Web of Science ®Google Scholar
• McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol 2006;17:170–5
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–83
   PubMed Web of Science ®Google Scholar
• Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001;50:2199–202
   PubMed Web of Science ®Google Scholar
• Lu SC, Shieh WY, Chen CY, et al. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002;530:158–62
   PubMed Web of Science ®Google Scholar
• Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003;300:472–6
   PubMed Web of Science ®Google Scholar
• Sunden-Cullberg J, Nystrom T, Lee ML, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 2007;35:1536–42
   PubMed Web of Science ®Google Scholar
• Bertolani C, Sancho-Bru P, Failli P, et al. Resistin as an intrahepatic cytokine: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 2006;169:2042–53
   PubMed Web of Science ®Google Scholar
• Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789–95
   PubMed Web of Science ®Google Scholar
• Schaffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. J Am Med Assoc 2003;290:1709–10
   PubMed Web of Science ®Google Scholar
• Senolt L, Housa D, Vernerova Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007;66:458–63
   PubMed Web of Science ®Google Scholar
• Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596–604
   PubMedGoogle Scholar
• Yura S, Sagawa N, Itoh H, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003;88:1394–7
   PubMed Web of Science ®Google Scholar
• Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxford) 2007;66:447–53
   PubMed Web of Science ®Google Scholar
• Nien JK, Mazaki-Tovi S, Romero R, et al. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 2007;35:513–21
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Mazaki-Tovi S, et al. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Mater-Fetal Neonatal Med 2008;21:902–16
   PubMed Web of Science ®Google Scholar
• Sagawa N, Yura S, Itoh H, et al. Role of leptin in pregnancy – a review. Placenta 2002;23:S80–86
   PubMed Web of Science ®Google Scholar
• Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005;186:457–65
   PubMed Web of Science ®Google Scholar
• Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 1995;378:776–9
   PubMed Web of Science ®Google Scholar
• Pagano G, Castello G. Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Exp Med Biol 2012;724:291–9
   PubMed Web of Science ®Google Scholar
• Burgio GR, Lanzavecchia A, Maccario R, et al. Immunodeficiency in Down’s syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol 1978;33:298–301
   PubMed Web of Science ®Google Scholar
• Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 2009;156:189–93
   PubMed Web of Science ®Google Scholar
• Sherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q produced exclusively in adipocytes. J Biol Chem 1995;270:26746–9
   PubMedGoogle Scholar
• Vrachnis N, Belitsos P, Sifakis S, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol 2012;2012:549748
   PubMed Web of Science ®Google Scholar
• Ng PC, Lee CH, Lam CW, et al. Resistin in preterm and term newborns: relation to anthropometry, leptin, and insulin. Pediatr Res 2005;58:725–30
   PubMed Web of Science ®Google Scholar
• Di Simone N, Di Nicuclo F, Sanguinetti M, et al. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol 2006;189:691–9
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Botsis D, Iliodromiti Z. The fetus that is small for gestational age. Ann N Y Acad Sci 2006;1092:304–9
   PubMed Web of Science ®Google Scholar
• Ng PC, Lee CH, Lam CW, et al. Plasma ghrelin and resistin concentrations are suppressed in infants of insulin-dependent diabetic mothers. J Clin Endocrinol Metab 2004;89:5563–8
   PubMed Web of Science ®Google Scholar
• Gohlke BC, Bartmann P, Fimmers R, et al. Fetal adiponectin and resistin in correlation with birth weight difference in monozygotic twins with discordant growth. Horm Res 2008;69:37–44
   PubMedGoogle Scholar
• Botsis D, Vrachnis N, Christodoulakos G. Doppler assessment of the intrauterine growth-restricted fetus. Ann N Y Acad Sci 2006;1092:297–303
   PubMed Web of Science ®Google Scholar
• Kalampokas E, Vrachnis N, Samoli E, et al. Association of adiponectin and placental growth factor in amniotic fluid with second trimester fetal growth. In Vivo 2012;26:327–33
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252–6
   PubMed Web of Science ®Google Scholar
• Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988;81:102–10
   PubMed Web of Science ®Google Scholar
• Luke A, Roizen NJ, Sutton M, Shcoeller DA. Energy expenditure in children with Down syndrome: correcting metabolic rate for movement. J Pediatr 1994;125:829–38
   PubMed Web of Science ®Google Scholar